RxDoctor Payments Data

Tyler Hauswald, PA

Physician Assistant · Wahoo, NENPI 1740270446

Payments from drug & device makers

$1,288in general payments, 2019–2025

Across 85 payments — averaging $15.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$594
  • Otsuka America Pharmaceutical, Inc.$96
  • Novartis$82
  • Johnson & Johnson$68
  • Amgen$67
  • Pfizer$42
  • plus $339 from 14 others

What the payments were for

  • Food & beverage$1,288100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,288 in reported general payments places this provider in the 75th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$1,859
Medicare patients
11
Services billed
19

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban76$47,241
OzempicSemaglutide40$45,763
JanuviaSitagliptin Phosphate35$19,254
JardianceEmpagliflozin24$18,740
XareltoRivaroxaban36$18,112
Breo ElliptaFluticasone/Vilanterol39$17,757
LinzessLinaclotide19$14,821
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt13$12,619
InvokanaCanagliflozin15$12,368
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,768
TradjentaLinagliptin13$6,300
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,066
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$4,523
Paliperidone ErPaliperidone11$3,297
LivaloPitavastatin Calcium11$2,922

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$42$47,24176 claims
Novo NordiskOzempic$31$45,76340 claims
Johnson & JohnsonXarelto, Invokana$68$30,48051 claims
MerckJanuvia$39$19,25435 claims
AbbVieLinzess, Synthroid$594$15,85835 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Wahoo

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →